Regeneron up on Eylea sales

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) gained $8.96 (14%) to $74.44 on Tuesday after releasing preliminary sales results for recently launched Eylea aflibercept and introducing 2012 guidance for...